Private carrier Jet Airways on Monday gained about seven per cent on the Bombay Stock Exchange after returning to profit in its December quarter results.Shares of the company closed at Rs 774.20, up Rs 50 or 6.99 per cent, after touching an intra-day high of Rs 799. A total of 4.25 lakh shares changed hands on the BSE.
On NSE, the scrip soared to an intra-day high of Rs 798 while it settled at Rs 774.10, gaining 6.93 per cent.
However, the company's shares have lost nearly 32 per cent in the past year. The 52-week high touched by the scrip was Rs 1178.90 on January 20, 2006 on the BSE.
Courtesy : expressindia.com
Jet Airways surges 7 pc on bourses
January 23, 2007, 9:20 amTCS to boost headcount
January 23, 2007, 9:18 am
Tata Consultancy Services Ltd, India's top software services exporter, sees strong orders and revenues in the year ahead, driven by robust demand in Asia and Europe, and plans to boost its headcount aggressively.The company, part of India's salt-to-software conglomerate Tata Group, has been thriving on an outsourcing boom as companies worldwide try to cut costs at home to stay competitive.
A large pool of English-speaking engineers and cheaper wages have helped Indian firms attract these deals in the past decade.
Girija Pande, TCS' Asia Pacific director, said in an interview on Monday the group had 10 outsourcing deals of USD 50 million to USD 100 million in the pipeline, and expects to close a few of them in the 2007 calendar year.
Courtesy : expressindia.com
A large pool of English-speaking engineers and cheaper wages have helped Indian firms attract these deals in the past decade.
Girija Pande, TCS' Asia Pacific director, said in an interview on Monday the group had 10 outsourcing deals of USD 50 million to USD 100 million in the pipeline, and expects to close a few of them in the 2007 calendar year.
Courtesy : expressindia.com
Dr Reddys Q3 net at Rs 503 crore
January 23, 2007, 9:16 am
Hyderabad-based pharma major Dr Reddys Laboratories today reported a net profit of Rs 503.49 crore for the quarter ended December 31, 2006, while its overall revenues crossed the one billion dollar mark on the back of two major acquisitions.The company said its total income (net of excise) of the at the end of the December quarter stood at Rs 1212.11 crore, while the same was recorded at Rs 532.22 crore for the quarter ended December 31, 2005, Dr Reddy's informed the BSE.
"For the first time in the history of Dr Reddys, we have crossed USD 1 billion in revenues. Starting as an API manufacturer addressing the Indian market over the last 22 years, Dr Reddys has grown into a vertically integrated global pharmaceutical company with activities spanning the entire pharmaceutical value chain," Dr Reddys CEO GV Prasad said.
The consolidated results of the current quarter include the results acquisitions of Germany's Betapharm and Roche group company, Industrias Quimicas Falcon de Mexico, therefore, not comparable with the previous period, DRL said.
Courtesy : expressindia.com
"For the first time in the history of Dr Reddys, we have crossed USD 1 billion in revenues. Starting as an API manufacturer addressing the Indian market over the last 22 years, Dr Reddys has grown into a vertically integrated global pharmaceutical company with activities spanning the entire pharmaceutical value chain," Dr Reddys CEO GV Prasad said.
The consolidated results of the current quarter include the results acquisitions of Germany's Betapharm and Roche group company, Industrias Quimicas Falcon de Mexico, therefore, not comparable with the previous period, DRL said.
Courtesy : expressindia.com
Page :
1